Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
about
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerationsmPEG-PLA/TPGS mixed micelles via intranasal administration improved the bioavailability of lamotrigine in the hippocampus.Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill.
P2860
Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Antitubercular Agent Delamanid ...... d Solute Carrier Transporters.
@en
Antitubercular Agent Delamanid ...... d Solute Carrier Transporters.
@nl
type
label
Antitubercular Agent Delamanid ...... d Solute Carrier Transporters.
@en
Antitubercular Agent Delamanid ...... d Solute Carrier Transporters.
@nl
prefLabel
Antitubercular Agent Delamanid ...... d Solute Carrier Transporters.
@en
Antitubercular Agent Delamanid ...... d Solute Carrier Transporters.
@nl
P2093
P2860
P356
P1476
Antitubercular Agent Delamanid ...... d Solute Carrier Transporters.
@en
P2093
Eiji Kashiyama
Hiroyuki Sasabe
Ken Umehara
Kenta Hashizume
Masakazu Shibata
Yoshihiko Shimokawa
Yoshihiro Ohzone
Yusuke Hamasako
P2860
P304
P356
10.1128/AAC.03049-15
P407
P577
2016-03-28T00:00:00Z